Research

DxTerity’s objective is to deliver our powerful genomic testing technology into routine medical care across a broad range of diseases and chronic conditions through key strategic partnerships.            

Our academic partner initiative provides research scientists with access to the DxDirect™ gene expression analysis technology and custom reagents to advance discovery for screening and prognosis in a wide variety of human conditions. DxDirect™ is ideally suited for rapid migration into applied clinical research and ultimately into routine clinical use.

Use DxDirect™ for research in oncology, inflammation, and host immune response using whole blood or FFPE tissue: 

• Explore and verify the utility, value, and potential applications of your complex genomic research findings.
• Simplify analysis for improved predictability and success during external clinical validation.
• Confirm your discoveries in a testing format that can be easily integrated into routine medical care.

learn more...